Previous studies have reported that increased HIF3α promoter methylation is associated with obesity and higher plasma glucose levels and waist-hip ratio (71, 100) and adipose tissue dysfunction, T2DM and lower insulin sensitivity (70, 71, 101). Here, HIF3A is linked to obesity due to melanocortin 4 receptor deficiency.